Rapid Nutrition Advances Production of Flagship Brands to Enter Thriving Asia Pacific Market
London, United Kingdom – 27 June 2023, - Rapid Nutrition PLC (Euronext Growth: ALRPD), a globally renowned natural wellness company, is delighted to announce significant progress in advancing the production and distribution of its flagship weight loss brand SystemLS, and its patented herbal immunity formula Azurene, with a strong focus on entering the flourishing Asia Pacific market.
Leveraging the recent funding agreement with Atlas Special Opportunities LLC, Rapid Nutrition's management team is driving forward with unwavering determination to position the company for success in this highly lucrative Asia Pacific region “APAC”, which is home to half the worlds under thirty population and internet users.
The funding agreement with Atlas Special Opportunities marks a transformative moment for Rapid Nutrition, representing a resounding endorsement of the company's vision, potential, and management team. This strategic partnership goes beyond mere financial support, providing Rapid Nutrition with invaluable resources and strategic guidance to propel its growth and unlock unparalleled opportunities in the global wellness market.
With the allocated funding, Rapid Nutrition is poised to accelerate its expansion plans and drive growth in key focus markets, particularly in the Asia Pacific region, with a focus on ecommerce as a powerful tool for rapid market entry. The financial resources provided by Atlas Special Opportunities will fuel Rapid Nutrition's initiatives in manufacturing, attracting key partners in-market, brand advertising, and operational capabilities. By focusing on these strategic areas, Rapid Nutrition aims to solidify its position as a market leader, generating substantial long-term value for its shareholders.
Simon St. Ledger, CEO of Rapid Nutrition, expressed his enthusiasm, stating, "We are thrilled to report our progress in preparing for entry into the APAC market. With the unwavering support of our strategic partner, Atlas Special Opportunities and the expertise of our management team, we are strategically positioned to capitalise on the tremendous growth potential in Asia’s health and wellness sector. Our flagship brands have achieved remarkable success in other markets, and we are confident that they will resonate with discerning APAC consumers who prioritise quality and natural ingredients."
The company's unwavering commitment to excellence is evident in its meticulous approach to product development and manufacturing. Rapid Nutrition ensures that its flagship brands maintain the highest standards of quality and efficacy, embodying the company's ethos of products "made by nature, refined by science."
Rapid Nutrition remains committed to maintaining transparent and open communication with its valued shareholders and the capital markets. As the company progresses in its pursuit of entering the emerging Asia Pacific markets, key milestones, partnerships, and market penetration strategies, will be diligently shared to keep stakeholders informed and engaged.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).